Explore the revolutionary impact of immunotherapy in cancer treatment through this 17-minute webinar featuring Dr. Lucia Possamai, Honorary Senior Clinical Lecturer at Imperial College London and Consultant Hepatologist at Imperial College Healthcare NHS Trust. Discover the dual nature of immunotherapy as both a breakthrough and challenge in modern oncology, with particular focus on checkpoint inhibitor biology and treatment approaches in hepatitis-related conditions. Learn from Dr. Possamai's specialized research insights into how these cutting-edge treatments are transforming patient care while presenting unique clinical considerations. Gain understanding of the complex mechanisms behind checkpoint inhibitors and their therapeutic applications in liver-related cancers and hepatitis treatment protocols.